Although FGF21 has several beneficial effects for glucose and lipid metabolism [78], circulating FGF21 levels are paradoxically increased in humans with obesity, metabolic syndrome [79,80], and NAFLD [81,82,83]. This evidence concerns the gene FGF21 and metabolic syndrome.